已收录 268921 条政策
 政策提纲
  • 暂无提纲
Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease
[摘要] State-of-the-art drug-eluting metal stents are the gold standard for interventional treatment of coronary artery disease. Although they overcome some disadvantages and limitations of plain balloon angioplasty and bare-metal stents, some limitations apply, most notably a chronic local inflammatory reaction due to permanent implantation of a foreign body, restriction of vascular vasomotion due to a metal cage, and the risk of late and very late stent thrombosis. The development of biodegradable scaffolds is a new approach that attempts to circumvent these drawbacks. These devices provide short-term scaffolding of the vessel and then dissolve, which should theoretically circumvent the side effects of metal drug-eluting stents. Various types of these bioresorbable scaffolds are currently under clinical evaluation. This review discusses different concepts of bioresorbable scaffolds with respect to material, design, and drug elution and presents the most recent evidence. (C) 2014 by the American College of Cardiology Foundation.
[发布日期] 2014-12-16 [发布机构] 
[效力级别]  [学科分类] 
[关键词] bioresorbable scaffold;coronary artery disease [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文